DoD Multiple Sclerosis, Clinical Trial Award

Archived

Defense Health Agency Contracting Activity - DHACA

Description

The MSRP Clinical Trial Award supports the rapid implementation of clinical trials with the potential to have a significant impact on the treatment or management of multiple sclerosis. Clinical trials may be designed to evaluate promising new products, pharmacologic agents (drugs or biologics), devices, clinical guidance, interventions, health behavioral modifications and/or emerging approaches and technologies. Proposed projects may range from small proof-of-concept trials (e.g., pilot, first in human, Phase 0), to demonstrate feasibility or inform the design of more advanced trials, through larger-scale Phase I and II trials to determine efficacy in relevant patient populations.

Who can apply

  • Unrestricted

Contact

CDMRP Help Desk <br/>Phone: 301-682-5507 <br/>Email: help@eBRAP.org
help@eBRAP.org

Key dates & funding
  • PostedApr 24, 2020
  • ClosesOct 1, 2020
  • Program funding$16,000,000
  • Expected awards2
  • CFDA12.420

Pro insight

Edit and export this grant’s proposal template, plus deadline reminders, similar-grant suggestions, and funder history — all available with Pro.

Unlock with Pro